1. 1585. Efficacy and safety of long-acting subcutaneous lenacapavir in heavily treatment-experienced people with multi-drug resistant HIV: Week 52 results. (15th December 2022) Authors: Ogbuagu, Onyema; Segal-Maurer, Sorana; Ratanasuwan, Winai; Trottier, Benoit; Brunetta, Jason; Shirasaka, Takuma; Koenig, Ellen L; Wang, Hui; Margot, Nicolas A; Dvory-Sobol, Hadas; Rhee, Martin S; Baeten, Jared; Molina, Jean-Michel Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 985. Impact of Age and Medical Comorbidities on Renal Outcomes in the DISCOVER Trial. (31st December 2020) Authors: Daar, Eric; Brunetta, Jason; Cua, Eric; Flamm, Jason; Asmuth, David; Carter, Christoph C; Shao, Yongwu; Wong, Pamela; Ebrahimi, Ramin; Das, Moupali; Brainard, Diana M; Clarke, Amanda Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of antiretroviral third agent virologic durability after initiation of first antiretroviral regimen. (June 2019) Authors: Varriano, Brenda; Sandler, Ina; Loutfy, Mona; Steinberg, Samantha; Smith, Graham; Kovacs, Colin; Brunetta, Jason; Fletcher, David; Knox, David; Merkley, Barry; Chang, Benny; Tilley, David; Acsai, Megan; Crouzat, Fred Journal: International journal of STD & AIDS Issue: Volume 30:Number 7(2019) Page Start: 680 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period. (1st January 2021) Authors: Rourke, Sean B.; Bekele, Tsegaye; Rachlis, Anita; Kovacs, Colin; Brunetta, Jason; Gill, M. John; Carvalhal, Adriana; Cysique, Lucette A.; Marcotte, Thomas; Power, Christopher Journal: AIDS Issue: Volume 35:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment. (1st May 2016) Authors: Wohl, David; Oka, Shinichi; Clumeck, Nathan; Clarke, Amanda; Brinson, Cynthia; Stephens, Jeffrey; Tashima, Karen; Arribas, Jose R.; Rashbaum, Bruce; Cheret, Antoine; Brunetta, Jason; Mussini, Cristina; Tebas, Pablo; Sax, Paul E.; Cheng, Andrew; Zhong, Lijie; Callebaut, Christian; Das, Moupali; Fo... Journal: Journal of acquired immune deficiency syndromes Issue: Volume 72:Number 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B–Coinfected Adults. (1st November 2016) Authors: Gallant, Joel; Brunetta, Jason; Crofoot, Gordon; Benson, Paul; Mills, Anthony; Brinson, Cynthia; Oka, Shinichi; Cheng, Andrew; Garner, Will; Fordyce, Marshall; Das, Moupali; McCallister, Scott Journal: Journal of acquired immune deficiency syndromes Issue: Volume 73:Number 3(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Changes in renal and metabolic indices after switching from tenofovir disoproxil fumarate– to tenofovir alafenamide–containing ART among individuals with HIV in Canada: A retrospective study. (August 2021) Authors: Shokoohi, Mostafa; Gupta, Meenakshi; Crouzat, Fred; Smith, Graham; Kovacs, Colin; Brunetta, Jason; Chang, Benny; Knox, David; Acsai, Megan; Merkley, Barry; Giolma, Kevin; Fletcher, David; Loutfy, Mona Journal: International journal of STD & AIDS Issue: Volume 32:Number 9(2021) Page Start: 861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 7 (July 2021) Authors: Ogbuagu, Onyema; Ruane, Peter J; Podzamczer, Daniel; Salazar, Laura C; Henry, Keith; Asmuth, David M; Wohl, David; Gilson, Richard; Shao, Yongwu; Ebrahimi, Ramin; Cox, Stephanie; Kintu, Alexander; Carter, Christoph; Das, Moupali; Baeten, Jared M; Brainard, Diana M; Whitlock, Gary; Brunetta, Jason... Journal: Lancet Issue: Volume 8:Issue 7(2021) Page Start: e397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P087 Providers' views on barriers and facilitators of bacterial STI testing among gbMSM living with or at risk for HIV. (14th July 2019) Authors: Guiang, Charlie; Burchell, Ann; Rana, Jayoti; Shahin, Rita; Brunetta, Jason; Mitterni, Leo; Tan, Darrell; Bacon, Jean; Gilbert, Mark; Gesink, Dionne; Grewal, Ramandip; Logie, Carmen; Yeung, Anna; Lisk, Ryan Journal: Sexually transmitted infections Issue: Volume 95(2019)Supplement 1 Page Start: A112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmacokinetics of Raltegravir in the Semen of HIV-Infectedmen. Issue 6 (August 2014) Authors: Antoniou, Tony; Loutfy, Mona R; Brunetta, Jason; Smith, Graham; Halpenny, Roberta; la Porte, Charles Journal: Antiviral therapy Issue: Volume 19:Issue 6(2014) Page Start: 607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗